维普中文期刊产品整合服务
40篇 您的检索式:作者名="Takekoshi N"
    题名 作者 年代 出处 被引量
1Cholesterol absorption inhibitors in de- velopment as potential therapeutics 显示文摘Kajinami K Takekoshi N 2002Expert Opin Investig Drugs2002,11,6:1
2Cholesterol absorption inhibitors in development as potential therapeutics 显示文摘Kajinami K Takekoshi N 2002Exp ()pin Investig Drugs2002,1,6:1
3Cholesterol absorption inhibitors in development as potential therapeutics 显示文摘KAJINAMI K TAKEKOSHI N 2002Exp Opin Investig Drugs2002,11,6:1
4Clinical significance of myocardial squeezing of the coronary artery 显示文摘Hasbimoto A Takekoshi N Murakami E 1984Jpn Heart J1984,25,6:1
5Cholesterol absorption inhibiltors in development as potential therapeutics显示文摘Kajinami K Takekoshi N 0,,03:1
6Cholesterol absorption inhibitoys in development as potential therapeutics显示文摘Kajinami K Takekoshi N 2002Expert Opln Investig Drugs2002,21,3:1
7Cholesterol absorption inhlbitors in developmtas potential therapeutics显示文摘Kajinami K Takekoshi N 2008Expect Opin Investig DrUgs2008,21,3:1
8Cholesterol absorption inhibitors indevelopment as potential therapeutics显示文摘Kajinami K Takekoshi N 2002Exp Opin InvestigDrugs2002,11,6:1
9Effect of pretreatment vitamin D levels on in vivo effects of atorvastatin on bone metabolism in patients with heterozygous familial hypercholesterolemia显示文摘Kajinami K Takekoshi N Matsui S 2003Am J Cardiol2003,92,9:1
10Pitavastatin:efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor显示文摘KAJINAMI K TAKEKOSHI N SAITO Y 2003Cardiovasc Drug Rev2003,21,3:1
11Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor显示文摘Kajinami K Takekoshi N Saito Y 2003Cardiovasc Drug Rev2003,21,3:1
12Cholesterol absorption inhibitors in development as potential therapeutics显示文摘KAJINAMI K TAKEKOSHI N 2002Expert Opinion on Investigational Drugs2002,11,6:1
13Pitavastatin,Efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor显示文摘Kajinami K Takekoshi N Saito Y 0,,03:1
14Cholesterol absorption inhibitors in development as potential therapeutics 显示文摘KAJINAMI K TAKEKOSHI N 2002Exp Opin Investig Drugs2002,11,6:1
15Imbalance of sex hormone levels in men with coronary artery disease显示文摘Kajinami K Takeda K Takekoshi N 2004Coron Artery Dis2004,15,4:1
16Pitavastatin:efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor显示文摘Kajinami K Takekoshi N Saito Y 2003Cardiovasc Drug Rev2003,21,3:1
17Cholesterol absorption inhibitors in development as potential therapeutics 显示文摘Kajinarni K Takekoshi N 2002Exp Opin Investig Drugs2002,11,6:1
18Pharmacogenetics of HMG-CoA reductase inhibitors:exploring the potential for genotype-based individualization of coronary heart disease management显示文摘Kajinami K Takekoshi N Brousseau ME 2004Atherosclerosis2004,177,:1
19Effect of pretreatmerit vitamin D levels on in vivo effects of atorvastatin on bone metabolism in patients with heterozygous familial hypercholesterolemia显示文摘Kajinami K Takekoshi N Matsui S 2003Am J Cardiol2003,92,9:1
20Cholesterol absorptian inhibitors in development as potential therapeutics显示文摘Kajinami K Takekoshi N 2002Expert Opin Investig Drugs2002,11,6:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费